Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass

[1]  Karen R Fitzgerald.  Review of article: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 by Katherine M. Flegal, PhD; Margaret D. Carroll, MSPH; Brian K. Kit, MD; Cynthia L. Ogden, PhD (JAMA 2012;307:491-7). , 2013, Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing.

[2]  C. Cooper,et al.  Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study , 2012, BMJ : British Medical Journal.

[3]  W. Schwesinger,et al.  Bariatric surgery and bone disease: from clinical perspective to molecular insights , 2012, International Journal of Obesity.

[4]  Amy D. Nguyen,et al.  Peptide YY Regulates Bone Remodeling in Mice: A Link between Gut and Skeletal Biology , 2012, PloS one.

[5]  Yuxiang Sun,et al.  An age-dependent interaction with leptin unmasks ghrelin's bone-protective effects. , 2012, Endocrinology.

[6]  R. Pietrobon,et al.  Changes in Bone Mineral Density in Women Following 1-Year Gastric Bypass Surgery , 2012, Obesity Surgery.

[7]  J. Aaseth,et al.  Osteoporosis and trace elements--an overview. , 2012, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[8]  C. Qualls,et al.  Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  G. Karsenty.  The mutual dependence between bone and gonads. , 2012, The Journal of endocrinology.

[10]  J. Holst,et al.  Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass , 2012, Diabetologia.

[11]  J. Cornish,et al.  Synthesis and evaluation of disulfide bond mimetics of amylin-(1-8) as agents to treat osteoporosis. , 2012, Bioorganic & medicinal chemistry.

[12]  J. Holst,et al.  Changes in Gastrointestinal Hormone Responses, Insulin Sensitivity, and Beta-Cell Function Within 2 Weeks After Gastric Bypass in Non-diabetic Subjects , 2012, Obesity Surgery.

[13]  Katherine M Flegal,et al.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.

[14]  J. Finkelstein,et al.  Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  R. Tamler,et al.  Sex hormones and bariatric surgery in men. , 2011, Gender medicine.

[16]  C. Combescure,et al.  Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. , 2011, The Journal of clinical endocrinology and metabolism.

[17]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[18]  N. Vilarrasa,et al.  Evaluation of Bone Mineral Density Loss in Morbidly Obese Women After Gastric Bypass: 3-Year Follow-Up , 2011, Obesity surgery.

[19]  M. Taskinen,et al.  Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes , 2011, Diabetes, obesity & metabolism.

[20]  S. Kini,et al.  GIP and Bariatric Surgery , 2011, Obesity surgery.

[21]  Roger J. R. Levesque,et al.  Obesity and Overweight , 2011 .

[22]  A. Scillitani,et al.  Sex hormones and bone health in males. , 2010, Archives of biochemistry and biophysics.

[23]  S. Portal-Nuñez,et al.  Presence of a functional receptor for GLP‐1 in osteoblastic cells, independent of the cAMP‐linked GLP‐1 receptor , 2010, Journal of cellular physiology.

[24]  R. DePinho,et al.  Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism , 2010, Cell.

[25]  Xiaoling Zhang,et al.  Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG‐63 cells , 2010, Cell biochemistry and function.

[26]  S. Boonen,et al.  IOF position statement: vitamin D recommendations for older adults , 2010, Osteoporosis International.

[27]  H. Berthoud,et al.  Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. , 2010, Endocrinology.

[28]  L. Furtado,et al.  Procedure and outcomes of Roux-en-Y gastric bypass. , 2010, British journal of nursing.

[29]  A. Klibanski,et al.  Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa. , 2010, Bone.

[30]  J. Teixeira,et al.  Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery , 2010, Journal of diabetes.

[31]  P. Schauer,et al.  Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes , 2010, International Journal of Obesity.

[32]  D. Pournaras,et al.  Ghrelin and Metabolic Surgery , 2010, International journal of peptides.

[33]  B. Riggs,et al.  Relation of Serum Serotonin Levels to Bone Density and Structural Parameters in Women , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  Luís Carlos do Rego Furtado.  Procedure and outcomes of Roux-en-Y gastric bypass. , 2010, British journal of nursing.

[35]  R. Considine,et al.  Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. , 2010, The Journal of clinical endocrinology and metabolism.

[36]  G. Karsenty,et al.  Leptin-dependent co-regulation of bone and energy metabolism , 2009, Aging.

[37]  G. Karsenty,et al.  A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms , 2009, Molecular and Cellular Endocrinology.

[38]  P. Hallberg,et al.  SSRIs, bone mineral density, and risk of fractures — a review , 2009, European Neuropsychopharmacology.

[39]  Kenji F. Tanaka,et al.  A Serotonin-Dependent Mechanism Explains the Leptin Regulation of Bone Mass, Appetite, and Energy Expenditure , 2009, Cell.

[40]  M. Sundbom,et al.  Serum Magnesium Status After Gastric Bypass Surgery in Obesity , 2009, Obesity surgery.

[41]  J. Cauley,et al.  Does Obesity Really Make the Femur Stronger? BMD, Geometry, and Fracture Incidence in the Women's Health Initiative‐Observational Study , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  A. Klibanski,et al.  Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls. , 2009, Bone.

[43]  P. Viviani,et al.  Increase of Bone Resorption and the Parathyroid Hormone in Postmenopausal Women in the Long-term after Roux-en-Y Gastric Bypass , 2009, Obesity surgery.

[44]  N. Vilarrasa,et al.  Evaluation of Bone Disease in Morbidly Obese Women After Gastric Bypass and Risk Factors Implicated in Bone Loss , 2009, Obesity surgery.

[45]  I. Reid,et al.  In vitro and in vivo effects of adiponectin on bone. , 2009, Endocrinology.

[46]  J. Vendrell,et al.  Regulation of Bone Mineral Density in Morbidly Obese Women: A Cross-sectional Study in Two Cohorts Before and After Bypass Surgery , 2009, Obesity surgery.

[47]  P. Esbrit,et al.  Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States , 2009, Calcified Tissue International.

[48]  M. Murr,et al.  Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesity. , 2009, Applied nursing research : ANR.

[49]  W. Lynch,et al.  The Impact of Morbid Obesity and Bariatric Surgery on Comorbid Conditions: A Comprehensive Examination of Comorbidities in an Employed Population , 2009, Journal of occupational and environmental medicine.

[50]  M. Olivares,et al.  Changes in Bone Mineral Density, Body Composition and Adiponectin Levels in Morbidly Obese Patients after Bariatric Surgery , 2009, Obesity surgery.

[51]  S. Hunt,et al.  Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. , 2009, The Journal of clinical endocrinology and metabolism.

[52]  D. Carrell,et al.  Male obesity and alteration in sperm parameters. , 2008, Fertility and sterility.

[53]  J. John Mann,et al.  Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum , 2008, Cell.

[54]  I. Reid,et al.  Modulation of osteoclastogenesis by fatty acids. , 2008, Endocrinology.

[55]  M. Bessler,et al.  The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. , 2008, The Journal of clinical endocrinology and metabolism.

[56]  C. Peterson,et al.  Impact of male obesity on infertility: a critical review of the current literature. , 2008, Fertility and sterility.

[57]  G. Karsenty,et al.  Reciprocal regulation of bone and energy metabolism. , 2008, Journal of musculoskeletal & neuronal interactions.

[58]  T. Mahdy,et al.  Effect of Roux-en Y Gastric Bypass on Bone Metabolism in Patients with Morbid Obesity: Mansoura Experiences , 2008, Obesity surgery.

[59]  J. Ling,et al.  Stimulation of intramembranous bone repair in rats by ghrelin , 2008, Experimental physiology.

[60]  Mark L. Johnson,et al.  Osteocytes, mechanosensing and Wnt signaling. , 2008, Bone.

[61]  M. Bessler,et al.  Markers of Bone and Calcium Metabolism Following Gastric Bypass and Laparoscopic Adjustable Gastric Banding , 2008, Obesity surgery.

[62]  W. Pories.  Ghrelin? Yes, it is spelled correctly. , 2008, Annals of surgery.

[63]  D. Drucker,et al.  The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. , 2008, Endocrinology.

[64]  H. Deng,et al.  Correlation of Obesity and Osteoporosis: Effect of Fat Mass on the Determination of Osteoporosis , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[65]  I. Reid.  Relationships between fat and bone , 2008, Osteoporosis International.

[66]  J. Herman,et al.  Peptide YY regulates bone turnover in rodents. , 2007, Gastroenterology.

[67]  H H Bolotin,et al.  DXA in vivo BMD methodology: an erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling. , 2007, Bone.

[68]  J. Dixon,et al.  Changes in Body Composition with Weight Loss: Obese Subjects Randomized to Surgical and Medical Programs , 2007, Obesity.

[69]  W. Richards,et al.  Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women , 2007, Surgical Endoscopy.

[70]  S. Hanazawa,et al.  Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans. , 2007, FEMS immunology and medical microbiology.

[71]  W. Bollag,et al.  Effects of glucose-dependent insulinotropic peptide on osteoclast function. , 2007, American journal of physiology. Endocrinology and metabolism.

[72]  G. Karsenty,et al.  Convergence between bone and energy homeostases: leptin regulation of bone mass. , 2006, Cell metabolism.

[73]  S. Shapses,et al.  True Fractional Calcium Absorption is Decreased After Roux‐En‐Y Gastric Bypass Surgery , 2006, Obesity.

[74]  A. Robling,et al.  Mechanical stimulation in vivo reduces osteocyte expression of sclerostin. , 2006, Journal of musculoskeletal & neuronal interactions.

[75]  Kozo Nakamura,et al.  Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways , 2006, Journal of cellular biochemistry.

[76]  Yuichiro Yamada,et al.  Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. , 2006, Molecular endocrinology.

[77]  E. DeMaria,et al.  The Long-term Effects of Gastric Bypass on Vitamin D Metabolism , 2006, Annals of surgery.

[78]  E. Barrett-Connor,et al.  Leptin Predicts BMD and Bone Resorption in Older Women but Not Older Men: The Rancho Bernardo Study , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[79]  D. Hosking,et al.  Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency , 2006, Osteoporosis International.

[80]  O. Johnell,et al.  Free Testosterone is an Independent Predictor of BMD and Prevalent Fractures in Elderly Men: MrOS Sweden , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[81]  I. Reid,et al.  Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. , 2006, Bone.

[82]  A. Klibanski,et al.  Elevated peptide YY levels in adolescent girls with anorexia nervosa. , 2006, The Journal of clinical endocrinology and metabolism.

[83]  K. Wynne,et al.  Attenuated peptide YY release in obese subjects is associated with reduced satiety. , 2006, Endocrinology.

[84]  W. Bollag,et al.  Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. , 2005, Bone.

[85]  T. Niu,et al.  The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. , 2005, Gene.

[86]  A. de Leiva,et al.  Effects of Bariatric Surgery on Vitamin D Status and Secondary Hyperparathyroidism: A Prospective Study , 2005, Obesity surgery.

[87]  H. Xie,et al.  Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. , 2005, Experimental cell research.

[88]  L. Campbell,et al.  The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. , 2005, European journal of endocrinology.

[89]  S. Bloom,et al.  Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. , 2005, The Journal of clinical endocrinology and metabolism.

[90]  M. Visser,et al.  Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. , 2005, The Journal of clinical endocrinology and metabolism.

[91]  M. Matsuda,et al.  Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. , 2005, Biochemical and biophysical research communications.

[92]  A. de Leiva,et al.  Unchanged Hypovitaminosis D and Secondary Hyperparathyroidism in Morbid Obesity after Bariatric Surgery , 2005, Obesity surgery.

[93]  S. Kini,et al.  Nutritional Deficiencies following Bariatric Surgery: What Have We Learned? , 2005, Obesity surgery.

[94]  S. Takeda,et al.  Ghrelin Directly Regulates Bone Formation , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[95]  D. Cocchi,et al.  Ghrelin regulates proliferation and differentiation of osteoblastic cells. , 2005, The Journal of endocrinology.

[96]  Henry Buchwald,et al.  Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.

[97]  C. Drevon,et al.  Adiponectin and its receptors are expressed in bone-forming cells. , 2004, Bone.

[98]  M. Diniz,et al.  Elevated serum parathormone after Roux-en-Y gastric bypass. , 2004, Obesity surgery.

[99]  P. R. S. Rocha,et al.  Calcium Metabolism in Pre- and Postmenopausal Morbidly Obese Women at Baseline and After Laparoscopic Roux-En-Y Gastric Bypass , 2004, Obesity surgery.

[100]  J. Sundsfjord,et al.  Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study. , 2004, European journal of endocrinology.

[101]  M. Brunette,et al.  Testosterone enhances calcium reabsorption by the kidney , 2004, Molecular and Cellular Endocrinology.

[102]  U. Keller,et al.  Changes in bone mineral content after surgical treatment of morbid obesity. , 2004, Metabolism: clinical and experimental.

[103]  T. Thomas.  The complex effects of leptin on bone metabolism through multiple pathways. , 2004, Current opinion in pharmacology.

[104]  C. Lamendola,et al.  Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. , 2004, The Journal of clinical endocrinology and metabolism.

[105]  R. Rizzoli,et al.  Dietary protein and bone health , 2003, Proceedings of the Nutrition Society.

[106]  P. Schauer,et al.  Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. , 2004, The Journal of clinical endocrinology and metabolism.

[107]  C. Laplace,et al.  Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo , 2004, The Journal of cell biology.

[108]  S. Shapses,et al.  Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. , 2004, Obesity research.

[109]  H. Noushmehr,et al.  Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. , 2003, Endocrinology.

[110]  J. Dixon,et al.  Body composition changes following laparoscopic gastric banding for morbid obesity , 2003, Acta Diabetologica.

[111]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[112]  R. Vettor,et al.  Relationship between leptin levels and bone mineral density in the elderly , 2003, Clinical endocrinology.

[113]  R. Batterham,et al.  The Gut Hormone Peptide YY Regulates Appetite , 2003, Annals of the New York Academy of Sciences.

[114]  J. Holst,et al.  Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. , 2003, The Journal of clinical endocrinology and metabolism.

[115]  G. Kisakol,et al.  Effect of Weight Loss on Bone Metabolism: Comparison of Vertical Banded Gastroplasty and Medical Intervention , 2003, Obesity surgery.

[116]  M. Holick.  Vitamin D: A millenium perspective , 2003, Journal of cellular biochemistry.

[117]  I. Reid,et al.  Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. , 2002, The Journal of endocrinology.

[118]  I. Reid.  Relationships among body mass, its components, and bone. , 2002, Bone.

[119]  Patricia Ducy,et al.  Leptin Regulates Bone Formation via the Sympathetic Nervous System , 2002, Cell.

[120]  H. Buchwald,et al.  Evolution of Operative Procedures for the Management of Morbid Obesity 1950-2000 , 2002, Obesity surgery.

[121]  L. Hofbauer,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[122]  Sundeep Khosla,et al.  Sex steroids and the construction and conservation of the adult skeleton. , 2002, Endocrine reviews.

[123]  E. Dellinger,et al.  Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. , 2002, The New England journal of medicine.

[124]  Richard P Lifton,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[125]  G. Thomas,et al.  Hypothalamic Y2 receptors regulate bone formation. , 2002, The Journal of clinical investigation.

[126]  F. Guillemin,et al.  Serum leptin level is a predictor of bone mineral density in postmenopausal women. , 2002, The Journal of clinical endocrinology and metabolism.

[127]  G. Nicholson,et al.  Leptin Inhibits Osteoclast Generation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[128]  C. Drevon,et al.  Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling , 2002, Journal of cellular biochemistry.

[129]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[130]  C. Drevon,et al.  Leptin Is Expressed in and Secreted from Primary Cultures of Human Osteoblasts and Promotes Bone Mineralization , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[131]  I. Reid,et al.  Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. , 2001, Bone.

[132]  B. Riggs,et al.  Leptin reduces ovariectomy-induced bone loss in rats. , 2001, Endocrinology.

[133]  R. Bollag,et al.  Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects , 2001, Molecular and Cellular Endocrinology.

[134]  J. Pasco,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Serum Leptin Levels Are Associated with Bone Mass in , 2022 .

[135]  R. Nuti,et al.  Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. , 2001, Bone.

[136]  M. Nakazato,et al.  Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. , 2000, Endocrinology.

[137]  C. Steppan,et al.  Leptin is a potent stimulator of bone growth in ob/ob mice , 2000, Regulatory Peptides.

[138]  H. Rasmussen,et al.  Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. , 2000, Endocrinology.

[139]  Arndt F Schilling,et al.  Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.

[140]  J. Himms-Hagen,et al.  Physiological roles of the leptin endocrine system: differences between mice and humans. , 1999, Critical reviews in clinical laboratory sciences.

[141]  P. Tothill,et al.  Anomalies in dual energy X-ray absorptiometry measurements of total-body bone mineral during weight change using Lunar, Hologic and Norland instruments. , 1999, The British journal of radiology.

[142]  M. Donath,et al.  Insulin-Like Growth Factor I , 1999, Drugs & aging.

[143]  Ostrowska,et al.  Assessment of bone metabolism in obese women. , 1998, Endocrine regulations.

[144]  A. Goulding,et al.  Plasma Leptin Values in Relation to Bone Mass and Density and to Dynamic Biochemical Markers of Bone Resorption and Formation in Postmenopausal Women , 1998, Calcified Tissue International.

[145]  O. Johnell,et al.  Osteopenia after gastrectomy, fundectomy or antrectomy: an experimental study in the rat , 1998, Regulatory Peptides.

[146]  I. Reid,et al.  Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. , 1998, American journal of physiology. Endocrinology and metabolism.

[147]  N. Udagawa,et al.  Insulin receptor expression in primary and cultured osteoclast-like cells. , 1998, Bone.

[148]  C. Ohlsson,et al.  Growth hormone and bone. , 1998, Endocrine reviews.

[149]  A. Ferrara,et al.  Effects of Amylin on Human Osteoblast-Like Cells , 1997, Peptides.

[150]  S. Dagogo-Jack,et al.  Augmentation of bone mineral density in hirsute women. , 1997, The Journal of clinical endocrinology and metabolism.

[151]  Validation of a dual energy X-ray absorptiometer: measurement of bone mass and soft tissue composition , 1998, European Journal of Applied Physiology and Occupational Physiology.

[152]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[153]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[154]  I. Reid,et al.  Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. , 1995, Biochemical and biophysical research communications.

[155]  Y. Lee,et al.  Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity. , 1994, The American journal of physiology.

[156]  N. Mauras,et al.  Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone. , 1994, The Journal of clinical investigation.

[157]  M. Zaidi,et al.  Amylin in bone conservation current evidence and hypothetical Considerations , 1993, Trends in Endocrinology & Metabolism.

[158]  P. Pietschmann,et al.  Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria. , 1993, Bone.

[159]  M. Zaidi,et al.  Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts , 1993, Experimental physiology.

[160]  F. S. Whaley,et al.  Biochemical Evidence of Metabolic Bone Disease in Women Following Roux-Y Gastric Bypass for Morbid Obesity , 1992, Obesity surgery.

[161]  M. Thomas,et al.  Testosterone Alters Duodenal Calcium Transport and Longitudinal Bone Growth Rate in Parallel in the Male Rat 1 , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[162]  J. Holst,et al.  Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. , 1992, The New England journal of medicine.

[163]  T. Hangartner,et al.  Influence of fat on bone measurements with dual-energy absorptiometry. , 1990, Bone and mineral.

[164]  J M Polak,et al.  Human distribution and release of a putative new gut hormone, peptide YY. , 1985, Gastroenterology.

[165]  S. Epstein,et al.  Evidence for alteration of the vitamin D-endocrine system in obese subjects. , 1985, The Journal of clinical investigation.

[166]  J. Compston,et al.  Vitamin D status and bone histomorphometry in gross obesity. , 1981, The American journal of clinical nutrition.